In addition, SmrtGraft: — is already being used safely in practice under the TGA’s Special Access Scheme; — is shown to be efficacious as the study submitted with the TGA application demonstrating that it achieved: • 100% successful in RC tendon repair for all patients (significant improvement in pain, function and quality of life); • No requirement for revision surgery for any re-tears (the current methods result in a high re-tear rate of up to 57%).
All factors point to this almost being a formality.
US$1.2 billion market is just for rotator cuff tendon repair, with possible expansion of this TAM if we later cover other tendon repairs like tendons in the knee, hip, ankle, wrist and hands.
OCC Price at posting:
$1.21 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)